Explore Business Standard
British FMCG major Reckitt's India business reported a "double-digit growth" in the first quarter of 2026, led by a strong growth of its key brands, such as Dettol, Durex and expansion in the coverage area. In India, two of Reckitt's brands, Dettol in the Germ Protection segment and Durex in Intimate Wellness, reported double-digit growth in the quarter. While at the group level, the net revenue of Reckitt, which owns power brands such as Dettol, Lysol, Mucinex, Finish, and Durex, was at 3.24 billion pounds, with a LFL growth of 0.6 per cent in Q1 of 2026. Its volume growth was 2 per cent. The quarter has been impacted by low seasonal incidence, weak categories in Europe and geopolitical disruption, according to an earnings statement from the company. However, its 'Core Reckitt', which houses its 11 "Powerbrands", reported a net revenue growth of 1.3 per cent in the first quarter, helped by emerging markets. This growth in Core Reckitt was "led by Emerging Markets, with double-dig
British FMCG major Reckitt on Wednesday said implementation of new GST slabs in India impacted its net revenue growth in the September quarter. However, the company reported volume-led growth in its germ protection brand Dettol in markets, including India, which helped it grow by double digits in the quarter. Besides, in the Intimate Wellness category, its brand Durex continued to gain market share in India, Reckitt said in its earnings statement. "We continued to drive encouraging sell-out performance in India, whilst LFL net revenue growth (low single digit) was impacted by the GST regime change in September. This resulted in a shift of trade orders to Q4," said Reckitt. However, this short-term disruption, Reckitt said, its "like-for-like (LFL) net revenue growth in India remains high single digit through 2025 YTD. Reckitt operates in the Indian market with power brands, which include Lysol, Vanish, Strepsils, Veet, Dettol, Harpic, and Durex. Leading FMCG makers in India repor